pubmed-article:16380474 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16380474 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:16380474 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
pubmed-article:16380474 | lifeskim:mentions | umls-concept:C0450127 | lld:lifeskim |
pubmed-article:16380474 | lifeskim:mentions | umls-concept:C2350466 | lld:lifeskim |
pubmed-article:16380474 | lifeskim:mentions | umls-concept:C0035015 | lld:lifeskim |
pubmed-article:16380474 | lifeskim:mentions | umls-concept:C1882923 | lld:lifeskim |
pubmed-article:16380474 | lifeskim:mentions | umls-concept:C1548437 | lld:lifeskim |
pubmed-article:16380474 | lifeskim:mentions | umls-concept:C0522536 | lld:lifeskim |
pubmed-article:16380474 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:16380474 | pubmed:dateCreated | 2005-12-28 | lld:pubmed |
pubmed-article:16380474 | pubmed:abstractText | A role of natural killer T (NKT) cells in transplant rejection remains unknown. Here, we determined whether NKT cells participate in rejection of islet allografts, using NKT cell-deficient mice. Survival of islet allografts in streptozotocin-induced diabetic CD1d(-/-) mice or Valpha14 NKT cell(-/-) mice was significantly prolonged without immunosuppression when grafted into the liver, but not beneath the kidney capsule, compared with wild-type mice. Acceptance of intrahepatic islet allografts was achieved in CD1d(-/-) mice by a subtherapeutic dose of rapamycin, which was abrogated in conjunction with the transfer of hepatic mononuclear cells from wild-type, but not from CD1d(-/-), mice at islet transplantation. The second islet grafts from a donor-specific, but not from a third-party, strain in CD1d(-/-) mice bearing functional islet allografts were accepted without immunosuppression at 120 days after the initial transplantation. These findings demonstrate that NKT cells play a significant role in rejection of islet allografts in the liver of mice, but that NKT cells are not essential for induction of donor-specific unresponsiveness in this model. The current study indicates that NKT cells might be considered as a target for intervention to prevent islet allograft rejection when the liver is the site of transplantation. | lld:pubmed |
pubmed-article:16380474 | pubmed:language | eng | lld:pubmed |
pubmed-article:16380474 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16380474 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:16380474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16380474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16380474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16380474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16380474 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16380474 | pubmed:month | Jan | lld:pubmed |
pubmed-article:16380474 | pubmed:issn | 0012-1797 | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:NakayamaToshi... | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:TaniguchiMasa... | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:TanakaMasaoM | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:OnoJunkoJ | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:SatohMasayuki... | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:IkedaSeiyoS | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:YasunamiYohic... | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:NakanoMasahik... | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:NabeyamaKenta... | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:ToyofukuAtsus... | lld:pubmed |
pubmed-article:16380474 | pubmed:author | pubmed-author:MatsuokaNobuh... | lld:pubmed |
pubmed-article:16380474 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16380474 | pubmed:volume | 55 | lld:pubmed |
pubmed-article:16380474 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16380474 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16380474 | pubmed:pagination | 34-9 | lld:pubmed |
pubmed-article:16380474 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:meshHeading | pubmed-meshheading:16380474... | lld:pubmed |
pubmed-article:16380474 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16380474 | pubmed:articleTitle | Natural killer T-cells participate in rejection of islet allografts in the liver of mice. | lld:pubmed |
pubmed-article:16380474 | pubmed:affiliation | Department of Surgery I, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan. | lld:pubmed |
pubmed-article:16380474 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16380474 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16380474 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16380474 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16380474 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16380474 | lld:pubmed |